↓ Skip to main content

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

Overview of attention for article published in Cancers, August 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Published in
Cancers, August 2023
DOI 10.3390/cancers15174265
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 4 9%
Student > Ph. D. Student 4 9%
Unspecified 3 7%
Researcher 2 5%
Other 1 2%
Other 2 5%
Unknown 28 64%
Readers by discipline
Readers by discipline Count As %
Unspecified 3 7%
Biochemistry, Genetics and Molecular Biology 3 7%
Medicine and Dentistry 3 7%
Business, Management and Accounting 1 2%
Linguistics 1 2%
Other 5 11%
Unknown 28 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2023.
All research outputs
#14,921,993
of 24,475,473 outputs
Outputs from Cancers
#5,954
of 14,526 outputs
Outputs of similar age
#107,439
of 249,484 outputs
Outputs of similar age from Cancers
#132
of 392 outputs
Altmetric has tracked 24,475,473 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 14,526 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,484 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 392 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.